Evidence map›Paper›PMID 37086737›Full record

ArticleThe Lancet. Microbe2023

Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study.

Hanna Y Ehrlich, A Fabrice Somé, Thomas Bazié, Cathérine Neya Ebou, Estelle Lotio Dembélé, Richard Balma, Justin Goodwin, Martina Wade, Amy K Bei, Jean-Bosco Ouédraogo and 3 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Microbe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Antimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hanna Y EhrlichDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA; One Health Institute, University of California, Davis, CA, USA. Electronic address: hanna.ehrlich@yale.edu.
A Fabrice SoméDepartment of Parasitology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Thomas BaziéDepartment of Parasitology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Cathérine Neya EbouDepartment of Parasitology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Estelle Lotio DembéléDepartment of Parasitology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Richard BalmaDepartment of Medical Entomology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Justin GoodwinDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA.
Martina WadeDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA.
Amy K BeiDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA.
Jean-Bosco OuédraogoDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA; Department of Parasitology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Brian D FoyDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
Roch K DabiréDepartment of Medical Entomology, Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Sunil ParikhDepartment of Epidemiology of Microbial Diseases, Yale University, New Haven, CT, USA.
Yale University · USColorado State University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malariaU01AI138910 · NIAID · COLORADO STATE UNIVERSITY · PI FOY, BRIAN DAVID, PARIKH, SUNIL · 2018 to 2022
$3.5M
Employing genetic and genomic surveillance to reveal mechanisms of malaria parasite persistenceK01TW010496 · FIC · YALE UNIVERSITY · PI BEI, AMY KRISTINE · 2016 to 2021
$754k
TRANSMIT: Tracking Antimalarial Resistance in Mosquito PopulationsR21AI135477 · NIAID · YALE UNIVERSITY · PI PARIKH, SUNIL · 2018 to 2019
$450k
Optimizing spatial sampling strategies for the molecular surveillance of drug resistant malariaF31AI150168 · NIAID · YALE UNIVERSITY · PI EHRLICH, HANNA · 2020 to 2022
$87k
FIC NIH HHS D43 TW010540FIC NIH HHS K01 TW010496NCATS NIH HHS UL1 TR001863NIAID NIH HHS F31 AI150168NIAID NIH HHS R21 AI135477NIAID NIH HHS U01 AI138910
6 · The paper itself

Abstract

backgroundStrong surveillance systems with wide geographic coverage are needed to detect and respond to reports of antimalarial drug resistance on the African continent. We aimed to assess the utility and feasibility of using blood-fed mosquitos (xenomonitoring) to conduct rapid surveillance of molecular markers associated with resistance in human populations.

methodsWe conducted three cross-sectional surveys in two rainy seasons and the interim dry season in southwest Burkina Faso between Oct 10, 2018, and Sept 17, 2019. We collected human blood samples and blood-fed mosquitos residing in household clusters across seven village sectors. Samples were assessed for Plasmodium falciparum with ultrasensitive quantitative PCR, genotyped for two markers of reduced drug susceptibility, pfmdr1 256A>T (Asn86Tyr) and pfcrt 227A>C (Lys76Thr), and sequenced for four markers of clonality. We assessed statistical equivalence using a 10% margin of equivalence.

findingsWe identified 551 infections in 1483 human blood samples (mean multiplicity of infection [MOI] 1·94, SD 1·47) and 346 infections in 2151 mosquito blood meals (mean MOI 2·2, SD 1·67). The frequency of pfmdr1 Asn86Tyr was 4% in survey 1, 2% in survey 2, and 12% in survey 3 in human samples, and 3% in survey 1, 0% in survey 2, and 8% in survey 3 in mosquito blood meals, and inter-host frequencies were statistically equivalent in surveys 1 and 2 (p<0·0001) but not Survey 3 (p=0·062) within a tolerability of 0·10. The frequency of pfcrt Lys76Thr was 16% in survey 1, 55% in survey 2, and 11% in survey 3 in humans and 40% in survey 1, 72% in survey 2, and 13% in survey 3 in mosquitos, and inter-host frequencies were equivalent in survey 3 only (p=0·032) within a tolerability of 0·10. In simulations, multiple but not preferential feeding behaviour in mosquitos reduced the accuracy of frequency estimates between hosts, particularly for markers circulating at higher frequencies.

interpretationMolecular markers in mosquito blood meals and in humans exhibited similar temporal trends but frequencies were not statistically equivalent in all scenarios. More work is needed to determine empirical and pragmatic thresholds of difference. Xenomonitoring might be an efficient tool to provide rapid information on emerging antimalarial resistance in regions with insufficient surveillance.

fundingNational Institute of Allergy and Infectious Diseases. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.

Indexed as

AntimalarialsCulicidaeFolic Acid AntagonistsAnimalsCross-Sectional StudiesHumansPlasmodium falciparumPolymerase Chain ReactionAntimalarialsFolic Acid Antagonists

Identifiers

PMID37086737
PMCPMC10365133
OpenAlexW4366529413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.